Hunan Fangsheng Pharmaceutical Co., Ltd.SSE: 603998

Announcement on Convening Performance Briefing for 2025 and Q1 2026

· Issued by Hunan Fangsheng Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

The briefing is scheduled for a specific date and will be held online at the Shanghai Stock Exchange Roadshow Center. The company aims to address investor questions regarding its operational results and financial indicators during this session. Participants will include key executives from the company, and investors can submit questions in advance.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Convening Performance Briefing for 2025 and Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Hunan Fangsheng Pharmaceutical Co., Ltd. on 6ix

Earlier from Hunan Fangsheng Pharmaceutical

Later from Hunan Fangsheng Pharmaceutical

All Hunan Fangsheng Pharmaceutical news releases